Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 11 - 20 of about 79   

Articles published

ARNA 6.37 +0.02 (0.31%)
price chart
Arena - Belviq Sales Up Modestly Heading Into Television Ads
It is certainly an interesting time to be an investor in Arena Pharmaceuticals (ARNA). The company is about 10 months into its launch of the anti-obesity drug Belviq and the equity has taken several lumps along the way.
Related articles »  
Latest Developments: Galena Biopharma Inc (NASDAQ:GALE), Arena ...
New York, NY - (MARKET NEWS CALL) - 4/16/2014� Galena Biopharma Inc (NASDAQ:GALE)'s shares dropped 7.45% to $1.74. Levi & Korsinsky on Apr. 10 announced that a class action lawsuit has been commenced in the United States District Court for ...
Biotech Active Runners: Arena Pharmaceuticals (NASDAQ:ARNA), Galena ...  Gaining Green
Related articles »  
Arena Pharmaceuticals, Inc. (ARNA) news: Arena Down With Overall Market ...
As we head toward the end of the first quarter, and the fiscal year end for Arena's (ARNA) marketing partner Eisai (OTCPK:ESALY), it is appropriate to assess where we are for both companies in terms of the sales for the anti-obesity drug Belviq.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Plans For A Bright Tomorrow
Dallas, Texas 03/19/2014 (ustradevoice) - Arena Pharmaceuticals Inc. (NASDAQ:ARNA) has been in the news lately for introducing the new drug BELVIQ.
To Play Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Patience Is Needed  WallStreetPR
Related articles »  
Biotech Active runners: Arena Pharmaceuticals (NASDAQ:ARNA), Halozyme ...
Sales of the Arena Pharmaceuticals Inc (NASDAQ:ARNA) anti-obesity drug Belviq have closed out the quarter on a positive note.
Traders Buzz: Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), Alcoa Inc (NYSE ...  Market News Call
Biotech Active Movers: Arena Pharmaceuticals (NASDAQ:ARNA), EXACT ...  eFinance Hub
Related articles »  
Arena Script Sales Close Out Quarter On Positive Note
Sales of the Arena Pharmaceuticals (ARNA) anti-obesity drug Belviq have closed out the quarter on a positive note. Sales improved throughout the quarter and are pacing well ahead of the previous quarter.
Why The Federal Employees Health Benefits Letter Is A Big Deal For Belviq
To understand why the FEHB letter is a very big deal for Arena (ARNA) and Eisai and Belviq sales, we need to know, who is the FEHB and who got the letter?
ARNA Crosses Below Key Moving Average Level
In trading on Thursday, shares of Arena Pharmaceuticals Inc (Symbol: ARNA) crossed below their 200 day moving average of $6.23, changing hands as low as $6.22 per share.
Notable Movers - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Regeneron ...
Las Vegas, NV - 14 April 2014 - (Tech Sonian) - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) provided a corporate update and reported financial results for the fourth quarter and fiscal year which ended on December 31, 2013.
Interesting ARNA Put And Call Options For May 30th
Investors in Arena Pharmaceuticals Inc (Symbol: ARNA) saw new options begin trading today, for the May 30th expiration. At Stock Options Channel , our YieldBoost formula has looked up and down the ARNA options chain for the new May 30th contracts and ...